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Technical limitations have prevented proteomic analyses of
events occurring less than 30 s after signal initiation. We
developed an automated, continuous quench-flow system
allowing quantitative proteomic assessment of very early cellular
signaling events (qPACE) with a time resolution of 1 s. Using
this technique, we determined that autophosphorylation of the
epidermal growth factor receptor occurs within 1 s after ligand
stimulation and is followed rapidly by phosphorylation of the
downstream signaling intermediates Src homologous and
collagen-like protein and phospholipase C gamma 1.
Quantitative proteomic approaches using mass spectrometry (MS)
have become the method of choice for the analysis of phosphorylation
events in vivo1. Stable isotope labeling by amino acids in cell culture
(SILAC)2, combined with treatment of cell populations at many time
points, has provided exciting insights into the spatio-temporal
dynamics of proteins in vivo3,4, including sites of transient phospho-
rylation upon growth-factor stimulation5. However, as MS-based
identification of phosphopeptides from rare and partially phospho-
rylated signaling molecules often requires large numbers of cells, the
scale of such experiments makes precise and uniform initiation and
monitoring of cellular signaling technically demanding. Although the
earliest reported time points of MS-based proteomics measurements
are therefore commonly at least 30 s after signal initiation, fluores-
cence lifetime measurements and kinetic studies have suggested that
autophosphorylation on receptor tyrosine kinases happens within
seconds after growth factor stimulation6–8.
The qPACE approach involves pumping SILAC-labeled cells
through a continuous quench-flow system to ensure rapid and
reproducible initiation and trapping of time-resolved cellular signaling
states. The method permits accurate, MS-based quantitative measure-
ments of signaling events, such as phosphorylation, on a timescale of
seconds. Using this system, we have analyzed phosphorylation of the
epidermal growth factor (EGF) receptor and its most proximal
signaling molecules, Src homologous and collagen-like protein (Shc)
and phospholipase C gamma 1 (PLCg) after 1, 5, 10 and 60 s of
EGF treatment.
The qPACE set-up consists of three peristaltic pumps that deliver
cells, stimuli and quenching reagent (Fig. 1a and Supplementary
Fig. 1 online). An experiment is performed by pumping cells and
growth factor into a mixing chamber to initiate stimulation. The
duration of stimulation is controlled by adjusting the flow rates and
the length of tubing between the mixing chamber and the point of
delivery of the quenching reagent, which blocks signaling. Immediate
quenching of all cellular activity is crucial for measurements of rapid
signaling events. This can be achieved by snap-freezing cells in liquid
nitrogen or by the addition of a fixing solution. Although cooling cells
with ice-cold solutions and processing them as rapidly as possible is
adequate for differential analyses of signaling events on a timescale of
minutes, it is not sufficient for a timescale of seconds. The use of 70%
ethanol at –20 1C gave the required quenching effect. This is a widely
used fixing solution and should trap all signaling events immediately
(Supplementary Methods online). A drawback of this approach is
that, when compared with lysing cells directly, ethanol reduces the
efficiency of EGF receptor (EGFR) immunoprecipitation by B50%
(data not shown). As pumping might be harmful to cells, we measured
their viability by staining with trypan-blue and using a NucleoCounter
before and after pumping, but observed no significant differences
(data not shown).
To determine site-specific phosphorylation events, we stimulated
HeLa S3 cells labeled with three distinct stable isotope forms of
arginine and lysine with 150 ng/ml EGF. We performed two sets of
experiments to profile phosphopeptides at five time points (0, 1, 5, 10
and 60 s) using 5 s as a common reference interval (Fig. 1b). After
quenching, cells were pelleted, lysed and subjected to immuno-
precipitation. Anti-phosphotyrosine antibodies were used to charac-
terize tyrosine phosphorylation sites on EGFR and downstream
signaling transducers. In a second set of experiments, EGFR was
immunoprecipitated with anti-EGFR antibody to determine the
profiles of serine and threonine phosphorylation sites on the receptor.
Immunoprecipitated proteins were separated by SDS-PAGE and
excised gel fragments were digested with trypsin. For anti-EGFR
immunoprecipitations, we excised a gel fragment based on the
expected migration of EGFR and for anti-phosphotyrosine immuno-
precipitations, we excised slices spanning the entire lane. Phospho-
peptides were purified by incubation with TiO2 spheres and analyzed
using Linear Ion Trap–Fourier Transform Ion Cyclotron Resonance
(LTQ-FTICR) and LTQ-Orbitrap mass spectrometers5,9 (Supplemen-
tary Methods online). Labeled peptides appear as triplets that reflect
the relative amounts of peptide at three different time points (Fig. 1c).
Phosphopeptides were validated and quantified by MSQuant (http://
msquant.sourceforge.net/). All changes were expressed as fold-change
relative to the reference value and normalized to one at time zero
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(Supplementary Methods online). We were able to detect eight
phosphorylation sites on EGFR, three of which displayed more than
a twofold increase in phosphorylation within 5 s exposure to EGF
(Fig. 2a). Tyrosine phosphorylation is the hallmark of EGFR activa-
tion10–12 and accordingly, these three sites are tyrosine residues
Tyr1092, Tyr1172, and Tyr1197. The latter
two are known binding sites for Shc, a signal
initiator in EGFR signaling5,12. The three sites
showing increased phosphorylation in o5 s
indicate that almost immediate autopho-
sphorylation of the receptor occurred. These
findings were also confirmed by western blot
analysis (Fig. 2b). The observation that the
abundances of corresponding nonphosphory-
lated peptides did not change substantially
suggests that only a small subset of receptor
molecules are involved in signal transduction
at this early stage (Supplementary Fig. 2
online). The nonregulated phosphorylation
sites comprise serine and threonine residues
known to participate in negative feedback
starting minutes after stimulation5,12–14.
Analysis of downstream signal components
revealed a regulated phosphotyrosine site in
Shc and two such sites in PLCg (Fig. 2a,b).
The phosphorylation of Shc at Tyr427 follows
immediately after phosphorylation of EGFR,
indicating that Shc and EGFR have to be in
close spatial proximity before stimulation.
Phosphorylation of the two regulated sites of
PLCg lagged behind; the phosphorylation of Tyr1253 was first
detected after 5 s and phosphorylation of Tyr771 was only detected
after 60 s. Two additional phosphotyrosine sites, Tyr16 in cell division
cycle 2 protein and Tyr707 in CUB domain–containing protein 1, were
not affected by EGFR stimulation even after 60 s (data not shown).
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Figure 1 qPACE-set up. (a) Three peristaltic pumps were used to
construct a continuous quench-flow system. Two pumps delivered cells
and EGF-containing solutions, respectively. The flow rate was adjusted
before the experiment, and the duration of stimulation was controlled
by the length of tubing that the cells and the stimulus had to pass
through before the reaction was quenched by –20 1C pre-chilled ethanol
delivered by a third pump. Nonstimulated control cells were pumped
through the 1 s set-up, using medium without EGF. Cells were kept in
an incubator at 37 1C until just before pumping, which was performed
at room temperature (23 1C). Results were in accordance with
experiments performed entirely at 37 1C (Supplementary Fig. 1 online).
(b) Cells were SILAC-encoded with normal and stable isotope-
substituted arginine and lysine, resulting in three cell populations
distinguishable by mass. Cells were stimulated with EGF for different times and mixed. The experiment was repeated to yield five time points. Combined
cells were lysed for affinity-purification using either anti-EGFR or anti-phosphotyrosine antibodies. The resulting protein complexes were separated by SDS-
PAGE and digested enzymatically. Phosphopeptides were enriched and analyzed by MS. (c) LTQ-FTICR mass spectra of phosphopeptide EGFR1189–1199
GSTAENAEpYLR. Numbering is based on the unprocessed receptor precursor. Different shades of gray correspond to the shades in Figure 1b, representing
different media used for cell labeling.
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Figure 2 Activation profiles of phosphopeptides. (a) Normalized time profiles of tyrosine, threonine and
serine phosphorylation sites, as detected by MS. Profiles of regulated phosphopeptides were recorded in
at least two biological replicates. The 5 s value was used as a common time point to integrate the time
series 0-5-10 s and 1-5-60 s. For normalization, the value at 0 s was set to 1 and the other values
adjusted accordingly. In the case of PLCg site Tyr1253, it was only detected after 5 s; therefore this
value was used for normalization. As PLCg site Tyr771 (PLCg764–778) was only detected after 60 s,
this prevented determination of an activation profile. (b) Regulated tyrosine phosphorylation sites
detected by qPACE were monitored by western blot analysis using site-specific antibodies. The three
isoforms of Shc (p66, p52 and p46) showed different activation profiles that could not be
discriminated at the peptide level as all three forms share the regulated tyrosine site.
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To our knowledge, this is the first report on a quantitative
proteomic assessment of very early signaling events in eukaryotic
cells. We demonstrated previously how MS-based proteomics enables
endogenous signaling molecules and their individual phosphorylation
sites to be profiled5 to discriminate between closely related signaling
pathways15 and to identify novel interaction partners16. The qPACE
approach enables similar experiments to be performed on a timescale
of seconds to better distinguish molecules acting as sensors from
downstream transducers. This will enhance understanding of how
these molecules integrate signals to decide cell fate. The system can
also be used to identify genuine ligand-receptor or drug-receptor
complexes by excluding receptor candidates activated indirectly at a
later time point. We have analyzed the consequences of EGFR
stimulation for 1–60 s, but in principle it is possible to perform
reproducible measurements on a timescale of o1 s. Although our
results were obtained using suspension cells, use of microcarrier beads
extends the method to adherent cells (Supplementary Fig. 3 online).
Thus, qPACE is a generic method applicable to the study of early
signaling events in many cell culture systems.
Note: Supplementary information is available on the Nature Biotechnology website.
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